IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, pretreatment with compounds 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, 12 and 13 resulted in significant suppression of CML-AGE-mediated upregulation of Il6 (Fig. 5b).